Introduction
Epidermal Growth Factor-like Domain Multiple 6 (EGFL6), a member of the EGF repeat superfamily, plays a crucial role in regulating cell cycle progression, proliferation, and developmental processes. This secreted protein is characterized by a signal peptide, an EGF repeat region comprising four complete and one partial EGF-like repeats (three with a calcium-binding consensus sequence), an arg-gly-asp integrin association motif, and a MAM domain, which is believed to have adhesive properties. Human EGFL6 shares significant amino acid sequence identity with its mouse and rat counterparts (75% and 78%, respectively). During early development, EGFL6 is expressed in various fetal tissues, including the lung, heart, liver, spleen, cochlea, and placenta, as well as in meningioma tumors.
Description
Recombinant Human EGFL6, produced in HEK cells, is a polypeptide chain spanning from amino acid Asn at position 22 to amino acid Arg at position 363. It is fused to an FC and a 6 x His-tag at the C-terminus, resulting in a total of 348 amino acids. With a predicted molecular mass of 40-55kDa, the EGFL6 protein undergoes purification using proprietary chromatographic techniques.
Physical Appearance
Sterile Filtered White lyophilized powder.
Formulation
The EGFL6 protein was lyophilized from a 0.2µm filtered solution containing 20mM MES, 500mM NaCl, pH 6.0, and 5% Trehalose.
Solubility
To reconstitute the lyophilized EGFL6, it is recommended to dissolve it in sterile PBS at a concentration of 500µg/ml. This solution can then be further diluted in other aqueous solutions as needed.
Stability
Lyophilized EGFL6 remains stable at room temperature for up to 3 weeks. However, for long-term storage, it is recommended to store it desiccated below -18°C. After reconstitution, EGFL6 should be stored at 4°C for 2-7 days. For future use, store below -18°C. To ensure optimal stability during long-term storage, consider adding a carrier protein (0.1% HSA or BSA). Avoid repeated freeze-thaw cycles.
Purity
The purity of EGFL6 is determined to be greater than 95.0% using SDS-PAGE analysis.
Biological Activity
The biological activity of EGFL6 is assessed by its ability to support the adhesion of NIH-3T3 mouse embryonic fibroblast cells when immobilized. The expected ED50 for this effect is in the range of 1-5 µg/ml.
Synonyms
EGF Like Domain Multiple 6, MAM and EGF Domains-Containing Gene Protein, MAM and EGF Domain Containing, EGF-Like Protein 6, MAEG, EGF Repeat-Containing Protein 6, W80, EGFL6.
Source
HEK (Human embryonic kidney cells).